COMMUNIQUÉS West-GlobeNewswire

Ascendis Pharma A/S Announces Upcoming Investor Presentation in October
26/09/2019
COPENHAGEN, Denmark, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced [...]
CorMedix Inc. Announces Exercises of Outstanding Warrants
26/09/2019
BERKELEY HEIGHTS, N.J., Sept. 26, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
Imagin Medical Announces Meeting Regarding i/Blue’s Regulatory Pathway
26/09/2019
VANCOUVER, British Columbia and BOSTON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced it recently met [...]
Three Recent Preclinical Publications Highlight NMDA Receptor Activation Facilitated by Aptinyx’s NYX-2925
26/09/2019
Data published across three peer-reviewed journals elucidate novel mechanism leading to enhanced synaptic plasticity EVANSTON, Ill., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage [...]
Cocrystal Pharma to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
- Presentation on Friday, October 4 th at 1:45 PM ET - BOTHELL, WA, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company [...]
Gritstone Oncology to Present at Cantor Global Healthcare Conference
26/09/2019
EMERYVILLE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]
Catalyst Biosciences to Present at the Cantor Global Healthcare Conference
26/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that Nassim Usman, Ph.D., president and chief executive officer of Catalyst Biosciences, will [...]
MDxHealth Launches Capital Increase and Secures Debt Financing from Kreos Capital
26/09/2019
Press release Regulated information – Inside information 26 September 2019, 2:00 p.m. CEST IRVINE, CA, and HERSTAL, BELGIUM – 26 September 2019 – MDxHealth SA (Euronext Brussels: MDXH) (the " Company " or " MDxHealth [...]
MDxHealth Lance une Augmentation de Capital et Obtient un Financement par Emprunt auprès de Kreos Capital
26/09/2019
Communiqué de presse Information réglementée - Information privilégiée 26 septembre 2019, 14H00 HEC IRVINE, CA, et HERSTAL (BELGIQUE) – le 26 septembre 2019 – MDxHealth SA (Euronext Brussels: MDXH) (la " Société " ou " [...]
Apellis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
CRESTWOOD, Ky. and WALTHAM, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference
26/09/2019
LAKE FOREST, Ill., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Annual Cantor Fitzgerald Global Healthcare [...]
LogicBio Therapeutics to Present at October Conferences
26/09/2019
CAMBRIDGE, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today [...]
Immutep Announces Expansion of Part A of TACTI-002 Phase II Clinical Trial due to Positive Interim Data
26/09/2019
Requisite clinical responses achieved in cohort 1 of Part A (1 st line NSCLC) of TACTI-002 Phase II clinical trial to allow for recruitment of cohort 2 Recruitment of cohort 2 of Part A of TACTI-002, additional 19 [...]
Medtronic Announces New Clinical Trial to Study Infuse Bone Graft in TLIF Spine Procedures
26/09/2019
Medtronic Continues to Invest in Scientific Evidence for Expansion of Indications and Greater Clinical Understanding of Infuse™ Bone Graft DUBLIN and CHICAGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) [...]
PetVivo Holdings, Inc. Featured in New Research Update
26/09/2019
MINNEAPOLIS, MN, Sept. 26, 2019 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV), an emerging biomedical device company, is very pleased to announce that Marble Arch Research Inc., a leading independent equity [...]
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
26/09/2019
SAN DIEGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (“Arcturus” or the “Company”), a leading RNA medicines company focused on the discovery, development and commercialization of mRNA therapeutics for [...]
RedHill Biopharma Provides H2/2019 R&D Update
26/09/2019
TEL-AVIV, Israel and RALEIGH, N.C., Sept. 26, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company [...]
Global Marketing and Strategy Leader Martha Pease Joins BioSig Board of Directors
26/09/2019
Fortune 500 business veteran brings unrivalled expertise in building brands and transformational tech innovation Westport, CT, Sept. 26, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM), a medical device [...]
OpGen to Present on Guiding Precision Antibiotic Therapy with Rapid Genomics and Informatics at IDWeek 2019
26/09/2019
Acuitas® AMR Gene Panel and Acuitas Lighthouse® Software to be highlighted in a conference speaker session GAITHERSBURG, Md., Sept. 26, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc . (Nasdaq: OPGN) announced today that data from [...]

Pages